Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma
PR Newswire•20/08/2026•08:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.